Seeds Investor’s Repligen RGEN Stock Holding History

Seeds Investor’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,491	Closed	-$274K	–	225
2024 Q1	$274K	Sell	1,491 -300	-17%	-$57.1K	0.25%	112
2023 Q4	$322K	Buy	+1,791	New	+$279K	0.36%	89

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Seeds Investor's RGEN Position: Q2 2024 in Review

Seeds Investor sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,491 shares — an estimated $274K sold.

Seeds Investor first reported a position in RGEN in Q4 2023 and held it in 2 quarters. The position peaked at $322K in Q4 2023. 454 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

Seeds Investor reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
Seeds Investor sold 1,491 Repligen shares in Q2 2024, an estimated $274K.
Seeds Investor first reported a position in Repligen in Q4 2023 and held it in 2 quarters.
Seeds Investor's Repligen position peaked at $322K in Q4 2023.
454 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Seeds Investor's 13F filing for Q2 2024, filed 5 Aug 2024.